GlassScriptPhysician profile
Mohammed Mahdi
NPI 1891474946
$9,678.70
in general payments reported to CMS, 2019-2025
4 companies · $2,323 in 2025
The $2,323 reported for 2025 was more than what 95% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $3,168 · 2024: $4,187 · 2025: $2,323.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $4,785 · Food and Beverage: $4,456 · Education: $438.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $4,784.95 |
| Food and Beverage | $4,456.01 |
| Education | $437.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $6,821.42 | 2023-2025 | General - Therapies, Ams 700, Tactra |
| Coloplast Corp | $2,697.97 | 2023-2025 | Titan |
| Endo Pharmaceuticals INC. | $141.22 | 2023 | Xiaflex |
| Tolmar, INC. | $18.09 | 2025 | Jatenzo, Eligard |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mohammed Mahdi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.